Sign in
GOVXW Stock Price, Chart, Stats & News
GeoVax Labs, Inc.
Save
88,758
Market cap
–
Current P/E
–
Forward P/E
GOVXW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 98.35% |
Operating margin | -761.63% |
Pretax margin | -754.69% |
Net margin | -754.69% |
Effective tax rate | – |
ROA | -375.99% |
ROE | -489.66% |
D/E | – |
Interest coverage ratio | – |
GOVXW valuation
P/E | – |
P/S | 0.42x |
P/B | 0.23x |
P/CF | -0.05x |
P/FCF | -0.06x |
P/OCF | -0.05x |
PEG | -0.00x |
EV multiple | -0.25x |
About
GeoVax Labs, Inc. is a clinical-stage biotechnology firm dedicated to creating human vaccines and immunotherapies. The company's core mission involves tackling a range of infectious diseases and various solid tumor cancers. Their innovative approach is centered on a proprietary modified vaccinia ankara virus-like particle (MVA-VLP) vaccine platform.
Similar securities
Based on sector and market capitalization
Report issue